Chief among these changes is the formation of a new Life Science Services business unit that consolidates the company’s offerings in CDMO and contract testing services. The CDMO business will include traditional modalities such as monoclonal antibodies (mAbs) and high potency active pharmaceutical ingredients (HP-APIs), as well as new technologies such as antibody-drug conjugates (ADCs) and viral and genes (VGT).
The Life Sciences Services division will include sales and marketing, research and development, manufacturing and supply chain operations, according to MilliporeSigma. The division will be led by Dirk Lange, who will join the company on February 15 from KBI Biopharma, where he served as President and CEO.
In addition, MilliporeSigma consolidates its Research Solutions and Applied Solutions businesses into a single organization, Science and Lab Solutions (SLS). This business will offer products including reagents, consumables, devices, instruments, software and services for scientific discovery, as well as instruments, consumables and services for laboratory water, microbiology and biomonitoring, assay assays, analytical reagents and flow cytometry kits and instruments. The activity will be led by Jean-Charles Wirth, currently Head of Applied Solutions.
Within the company’s Integrated Supply Chain and Operations (ISCO), division general manager Christos Ross is retiring on March 31 and his successor will be Ivan Donzelot, who will join the company from 3M in Europe. . Finally, MilliporeSigma’s Process Solutions (PS) division will continue to be led by Andrew Bulpin and will continue to focus on pharmaceutical development and manufacturing.
Copyright © 2022 LabPulse.com